期刊文献+

原发性肝细胞癌组织中Syntaxin 8表达变化及意义 被引量:3

下载PDF
导出
摘要 目的观察突触融合蛋白8(Synatxin 8)在原发性肝细胞癌(HCC)组织中的表达变化,并探讨其意义。方法收集75例HCC患者术后肝癌组织及其对应癌旁肝硬化组织,采用组织芯片免疫组织化学染色及Western blotting方法检测Syntaxin 8蛋白表达,分析Syntaxin 8蛋白表达与HCC患者临床病理特征的关系。结果 HCC组织中Syntaxin 8蛋白表达较癌旁肝硬化组织明显下调,差异有统计学意义(P<0.05);Syntaxin 8蛋白表达与HCC患者的性别、年龄无关,而与肿瘤大小、TNM分期及淋巴结转移有关(P均<0.05)。结论 Syntaxin 8蛋白在HCC组织中呈低表达,Synatxin 8可能参与了HCC的发生发展。
出处 《山东医药》 CAS 北大核心 2016年第25期44-46,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(31271519)
  • 相关文献

参考文献16

  • 1Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
  • 2El-Serag HB,Rudolph KL.Hepatocellular Carcinoma:Epidemiology and Molecular Carcinogenesis[J].Gastroenterology,2007,132(7):2557-2576.
  • 3Jahn R,Scheller RH.SNAREs-engines for membrane fusion[J].Nat Rev Mol Cell Biol,2006,7(9):631-643.
  • 4Meng J,Wang J.Role of SNARE proteins in tumourigenesis and their potential as targets for novel anti-cancer therapeutics[J].Biochim Biophys Acta,2015,1856(1):1-12.
  • 5Collins LE,Decourcey J,Di Luca,et al.An Emerging Role for SNARE Proteins in Dendritic Cell Function[J].Front Immunol,2015,6:133.
  • 6Thoreau V,Bergès T,Callebaut I,et al.Molecular cloning,expression analysis,and chromosomal localization of human syntaxin8(STX8)[J].Biochem Biophys Res Commun,1999,257(2):577-583.
  • 7Chen YA,Scheller RH.SNARE-mediated membrane fusion[J].Nat Rev Mol Cell Biol,2001,2(2):98-106.
  • 8Teng FY,Wang Y,Tang BL.The syntaxins[J].Genome Biol,2001,2(11):3012.
  • 9乔贵宾,吴一龙,区伟,杨学宁,钟文昭,林嘉颖,赵建,谢丹,关新元.免疫组化方法检测肿瘤标志在肺癌组织芯片中表达的可靠性研究[J].肿瘤防治研究,2004,31(8):467-470. 被引量:11
  • 10Subramaniam VN,Loh E,Horstmann H,et al.Preferential association of syntaxin 8 with the early endosome[J].J Cell Sci,2000,113(6):997-1008.

二级参考文献10

  • 1Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens[J]. Nat Med, 1998, 4(7):844-847.
  • 2Cordon-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia[J]. Am J Pathol 1997, 147(2):545-560.
  • 3Mucci NR, Akdas G, Manely S, et al. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression[J]. Hum Pathol,2000, 31(4):406-414.
  • 4Drobnjak M, Latres E, Pollack D, et al. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft tissue sarcomas[J].J Natl Cancer Inst, 1994, 86(7):549-554.
  • 5Altman DG.Practical Statistics for Medical Research[M].1st edition.London.Chapman and Hall,1996.404-408.
  • 6Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumors types[J]. Clin Cancer Res, 1999, 5(8):1966-1975.
  • 7Richter J, Wagner U, Kononen J, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer[J]. Am J Pathol, 2000, 157(3):787-794.
  • 8Bubendorf L, Kononen J, Koivisto P, et al. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays[J].Cancer Res, 1999, 59(4):803-806.
  • 9Cordon-Cardo C, Richon VM.Expression of the retinoblastoma protein is regulated in normal human tissues[J].Am J Pathol,1994, 144(3):500-510.
  • 10Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene[J]. Nature,1991, 351(6326):453-456.

共引文献10

同被引文献22

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部